Safety and Intraocular Pressure (IOP)-Lowering Efficacy of AL-39256 in Patients With Open-Angle Glaucoma or Ocular Hypertension

• Status: Completed
• Trial end date: 2009-10-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to evaluate the safety and intraocular pressure (IOP)-lowering efficacy of AL-39256 in patients with open-angle glaucoma or ocular hypertension.

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Alcon Research
• Treatments: Latanoprost; Ophthalmic Solutions

Criteria

Inclusion Criteria:

• Diagnosed with open-angle glaucoma or ocular hypertension.

• Other protocol-defined inclusion criteria may apply.

Exclusion Criteria:

• Females of childbearing potential.

• Other protocol-defined exclusion criteria may apply.